Document Detail


Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure.
MedLine Citation:
PMID:  21627396     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objectives: We evaluated performance and clinical acceptability of a new peripheral intravenous catheter (PIVC) designed to reduce blood exposure. Methods: A two phased, unblinded, randomized controlled trial was conducted at a clinical research center in New Jersey, USA. In Phase 1, clinicians were asked to evaluate two devices: a PIVC with blood control (BD Insyte Autoguard * BC [Blood Control] Shielded IV Catheter), and a reference conventional PIVC (BD Insyte Autoguard Shielded IV Catheter). In Phase 2, clinicians compared two insertions of the investigational PIVC with blood control (PIVC-BC); one with venous compression and one without. The PIVC-BC was evaluated for superiority to the conventional PIVC with regard to blood exposure and for equivalence in general performance characteristics. Results: Seventy-eight clinicians (mean age: 41.4 years; 89.7% female) and 234 healthy volunteers (mean age: 40.2 years; 61.5% female) were enrolled. Blood leakage occurred significantly more in the conventional PIVC group (39.1%) as compared to the PIVC-BC group (2.0%) (difference: 37.1% [95% CI: 28.8%; 45.15%]). Blood leakage rates for the PIVC-BC with or without use of venous compression were similar, 2.6% and 1.3% respectively (difference: 1.3% [95% CI: -7.8%; 4.7%]). A total of 98.7% of clinicians rated the PIVC-BC as clinically acceptable compared to 89.6% with the reference PIVC (difference: -9.1; 95% CI: -18; -1.5%) and 98.7% agreed it replaced the need for venous compression during catheter insertion (95% CI: 92.8%; 100%). Although the inability to blind clinicians to the investigational product was a potential source of bias, this was unlikely to affect assessments of observed blood leakage. Conclusions: The PIVC with blood control demonstrated reduced blood leakage during insertion and was rated no different for clinical acceptability and insertion performance compared to the conventional PIVC. Clinicians agreed that the new design replaced the need for venous compression to control blood flow during IV catheter insertion.
Authors:
Rudy Onia; Ingrid Eshun-Wilson; Christina Arce; Christopher Ellis; Valentin Parvu; David Hassman; Kenneth Kassler-Taub
Related Documents :
12390946 - Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blo...
12803846 - Clinical biochemical tissue monitoring during ischaemia and reperfusion in major vascul...
16235426 - Influence of eye closing on the cardiovascular response to stand test on stable and uns...
7493206 - The application of blood flow measurements to the study of aging muscle.
18945276 - Cerebral tissue oxygenation index and superior vena cava blood flow in the very low bir...
7100636 - Effect of hypoxia on the acute toxicity of acrylonitrile.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-31
Journal Detail:
Title:  Current medical research and opinion     Volume:  -     ISSN:  1473-4877     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-6-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Becton, Dickinson and Company , Sandy, UT , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial ischemia secondary to congenital hypoplastic left coronary cusp in adult.
Next Document:  Fundamental movement skills and self-concept of children who are overweight.